Director, President and CEO · Century Therapeutics, Inc. · Century Therapeutics, Inc. — Stock Option (right to buy)
Side
A
Value
—
Shares
945.0K
Price
—
Executed
Feb 2, 2026
Disclosed
Feb 4, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Feb 2 executedFeb 4, 2026 disclosed
IPSC · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+4 / 15
3 prior trades recorded in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Century Therapeutics, Inc. — Stock Option (right to buy)
Ticker
IPSC
Shares
945.0K
Price per share
$0
Execution date (reported)
Feb 2, 2026
Owned after transaction
945.0K shares
Days from execution to publication
2
What this establishes
Pfeiffenberger Brent filed this Form 4 reporting a grant or award of IPSC on Feb 2, 2026. It became public on Feb 4, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, President and CEO
Pfeiffenberger Brentcik:0002001162
Issuer
Century Therapeutics, Inc.cik:0001850119
Revision history · 0
No field has changed since this record was first ingested.
